NASDAQ
Agios Pharmaceuticals, Inc. (AGIO) has a price/sales ratio of 29.21x as of Friday, May 22, 2026. This represents a 43.12% decrease compared to its 12-month average of 51.35x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.